2026 ASCO Breast Cancer Highlights: Neo-Healer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

2026 ASCO Breast Cancer Highlights: Neo-Healer

Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the new Neo-Healer trial in HER2+ breast cancer.

  • October 15, 2026

Share

  • 1

    Harold Burstein, MD, PhD, and Adrienne Waks, MD, discuss the Neo-Healer trial.

  • 2

    The Neo-Healer trial concerns HER2-positive breast cancer.

  • 3

    The discussion is presented as part of the 2026 ASCO Breast Cancer Highlights.

  • 4

    The provided context does not describe the Neo-Healer trial design.

  • 5

    The provided context does not report Neo-Healer trial results.

Original Source(s)

2026 ASCO Breast Cancer Highlights: Neo-Healer

  • October 15, 2026

Related Content

Reading Skin Cancer’s Molecular Fingerprint

Machine-learning models analyzed Raman spectra to distinguish cancerous tissue from normal skin

  • October 6, 2026

  • 2 min
Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments)

Expanding surgical options for liver cancer and liver metastases

Advances in minimally invasive surgery and liver-directed therapies at UCI Health offer new treatment for complex liver malignancies.

  • October 14, 2026

  • 2 min